The Director, Value & Evidence – Xeljanz will support the strategic goals of the Inflammation and Immunology Business Unit (BU) by driving optimal patient access for Xeljanz This role directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance and robust evidence development relevant to achieve optimal patient access […]